Clinical Nurse Specialist Program year 2023 Reported 2021–2023 Source: CMS Open Payments, 2026 publication

Joann Calise

Clinical Nurse Specialist, Psychiatric/Mental Health, Adult Providence, RI Clinical Nurse Specialist

NPI 1861585630 CMS profile 10713811

345 Blackstone Blvd, Providence, RI 02906

Open in the dashboard

General payments

$2,661

132 records reported · program years 2021–2023

Research payments

$0

Paid to them · None reported · program years 2021–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Joann Calise of Providence, RI is reported in the CMS Open Payments database as having received $2,661 across 132 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 86th percentile of Clinical Nurse Specialist, Psychiatric/Mental Health, Adult profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $50 2
2022 General $542 30
2021 General $2,069 100

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Joann Calise
  • Clinical Nurse Specialist, Psychiatric/Mental Health, Adult median
  • Middle half of Clinical Nurse Specialist, Psychiatric/Mental Health, Adult
  • National median

In program year 2025, general payments to Joann Calise were reported at $0. Among 197 Clinical Nurse Specialist, Psychiatric/Mental Health, Adult profiles paid that year, the median was $174 and the middle half received between $71 and $653.

Show as a table
Year Joann Calise Clinical Nurse Specialist, Psychiatric/Mental Health, Adult median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $2,069 $152 $38–$472 $132
2022 $542 $172 $73–$546 $149
2023 $50 $156 $56–$560 $160
2024 $0 $158 $39–$521 $164
2025 $0 $174 $71–$653 $169

Breakdown

Who paid General payments · program years 2021–2023
  1. AbbVie, Inc. $947 48 payments
  2. Vanda Pharmaceuticals Inc. $418 15 payments
  3. Takeda Pharmaceuticals U.S.A., Inc. $352 15 payments
  4. Teva Pharmaceuticals USA, Inc. $195 10 payments
  5. Lundbeck LLC $162 11 payments
  6. Otsuka America Pharmaceutical, Inc. $121 7 payments
  7. ITI, Inc. $94 5 payments
  8. Sunovion Pharmaceuticals Inc. $89 6 payments
  9. Eisai Inc. $69 4 payments
  10. Neos Therapeutics, LP $64 3 payments
  11. Other $148 8 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2023
  1. Food and Beverage $2,661 132 payments
Products named General payments · program years 2021–2023
  1. VRAYLAR $947 48 payments
  2. HETLIOZ $418 15 payments
  3. FANAPT $418 15 payments
  4. TRINTELLIX $352 15 payments
  5. AUSTEDO $195 10 payments
  6. REXULTI Psychiatry $110 8 payments
  7. CAPLYTA $94 5 payments
  8. LATUDA $89 6 payments
  9. REXULTI Psychiatry $81 5 payments
  10. Dayvigo $69 4 payments
  11. Other $566 29 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

132 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Nurse Specialist, Psychiatric/Mental Health, Adult in Rhode Island

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record